CHA Vaccine Research Institute (KOSDAQ:261780)

KOSDAQ:261780 Statistics

Total Valuation

KOSDAQ:261780 has a market cap or net worth of KRW 77.10 billion. The enterprise value is 53.84 billion.

Market Cap	77.10B
Enterprise Value	53.84B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:261780 has 26.87 million shares outstanding. The number of shares has increased by 0.24% in one year.

Current Share Class	26.87M
Shares Outstanding	26.87M
Shares Change (YoY)	+0.24%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	0.02%
Float	15.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	486.10
PB Ratio	3.61
P/TBV Ratio	3.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.35
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.94

Financial Position

The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.50.

Current Ratio	3.78
Quick Ratio	3.27
Debt / Equity	0.50
Debt / EBITDA	n/a
Debt / FCF	-0.98
Interest Coverage	-5.15

Financial Efficiency

Return on equity (ROE) is -46.79% and return on invested capital (ROIC) is -17.47%.

Return on Equity (ROE)	-46.79%
Return on Assets (ROA)	-14.08%
Return on Invested Capital (ROIC)	-17.47%
Return on Capital Employed (ROCE)	-29.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-275.50M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.48% in the last 52 weeks. The beta is 0.69, so KOSDAQ:261780's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-29.48%
50-Day Moving Average	2,879.40
200-Day Moving Average	3,017.68
Relative Strength Index (RSI)	55.17
Average Volume (20 Days)	31,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:261780 had revenue of KRW 158.62 million and -12.37 billion in losses. Loss per share was -461.31.

Revenue	158.62M
Gross Profit	143.92M
Operating Income	-9.55B
Pretax Income	-12.64B
Net Income	-12.37B
EBITDA	-9.13B
EBIT	-9.55B
Loss Per Share	-461.31

Balance Sheet

The company has 33.90 billion in cash and 10.64 billion in debt, giving a net cash position of 23.26 billion or 865.79 per share.

Cash & Cash Equivalents	33.90B
Total Debt	10.64B
Net Cash	23.26B
Net Cash Per Share	865.79
Equity (Book Value)	21.36B
Book Value Per Share	795.07
Working Capital	29.65B

Cash Flow

In the last 12 months, operating cash flow was -10.73 billion and capital expenditures -169.92 million, giving a free cash flow of -10.90 billion.

Operating Cash Flow	-10.73B
Capital Expenditures	-169.92M
Free Cash Flow	-10.90B
FCF Per Share	-405.89

Margins

Gross Margin	90.73%
Operating Margin	-6,018.68%
Pretax Margin	-7,971.68%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:261780 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.24%
Shareholder Yield	n/a
Earnings Yield	-16.04%
FCF Yield	-14.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:261780 has an Altman Z-Score of 0.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.38
Piotroski F-Score	1